The Sauvignon Blanc Grapevine Improvement programme (SB2.0) was launched in 2021, with the aim of developing new Sauvignon blanc clones to help the NZ wine industry respond to a changing environment. Since then, we have been focused on developing capability within BRI’s Grapevine Improvement team and harnessing scientific technologies that are utilised within the modern plant improvement landscape. BRI have established a molecular laboratory that focuses on understanding the differences between grapevine varieties and unique clones of New Zealand’s premium variety, Sauvignon blanc.
In 2024, BRI planted a vineyard on the Lincoln University campus containing 6,000 unique Sauvignon blanc clones, with an additional 4,000 clones to be planted in 2025. These clones were created by harnessing the plant’s innate ability to adapt, generating random genetic changes following treatment with various stressors. These treatments do not introduce any new or foreign genetic material, resulting in vines that are non-GMO.
These plants will now be screened for key traits as defined by the industry. The traits include disease resistance, yield, drought tolerance (including water use efficiency), and frost tolerance. A key challenge is determining the most effective way to identify the clones with the traits of interest. With 10,000 vines to screen, we have employed high-throughput screening technologies to aid in this search.